Navigation Links
Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
Date:6/24/2011

focus our efforts on making this once-weekly therapy available to patients and healthcare providers in the U.S."

BYDUREON received marketing authorization in the European Union earlier this month. In the U.S., the FDA issued a complete response letter for the BYDUREON New Drug Application in late 2010. The companies plan to submit a response, including results of the thorough QT (tQT) study, in the second half of 2011. The tQT study uses intravenous exenatide to achieve plasma exenatide concentrations expected with BYDUREON, including the concentrations expected in patients with renal impairment.

BYDUREON is the proposed brand name for exenatide extended-release for injectable suspension. It is an investigational medication for type 2 diabetes designed to deliver continuous therapeutic levels of exenatide in a single weekly dose. BYDUREON is a once-weekly formulation of exenatide, the active ingredient in BYETTA® (exenatide) injection, which has been available in the U.S. since June 2005 and is used in more than 70 countries worldwide to improve glycemic control in adults with type 2 diabetes.

Analysis Design

This analysis included 148 patients with type 2 diabetes from the BYDUREON arm of DURATION-1, a phase 3, randomized, open-label, comparator-controlled trial. Electrocardiogram (ECG) recordings were performed at baseline; once steady-state plasma exenatide concentrations had been achieved following at least 14 weeks of treatment; and in a subset of patients at 30 weeks of treatment or sooner if the patient left the study early. Board-certified cardiologists who were blinded to treatment assignment performed analyses (interpretations) of all ECG tracings.

About Diabetes

Diabetes affects nearly 26 million people in the U.S. and an estimated 285 million adults worldwide.(ii, iii) Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes costs more than $174 billion per year in direc
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S.
2. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
3. PRA Early Phase Leaders to Speak at Bioanalysis Forum
4. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
5. Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
6. Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinsons Disease
7. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
8. Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
10. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... The report firstly reviews the basic information of ... manufacturing technology. The report then explores global and ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)...  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), an ... services for the lawfully organized cannabis industry, is ... the Company,s name and symbol change request. Effective ... known as Chuma Holdings, Inc. ... with the Company,s wholly-owned subsidiary, Chuma Holdings, Inc., ...
(Date:8/29/2014)... Aug. 29, 2014 The clinical and medical ... the difference between a product,s success or failure. Despite ... stratify KOL targets – and then to coordinate activities ... strong relationships upon which successful KOL engagement rests. ... have identified internal inconsistencies in their KOL management systems ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... , Aug. 4 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. (NYSE: ... to improving health through the development, manufacture and,commercialization of a broad range ... to release second quarter 2010,financial results on Monday, August 9, 2010 ... , , ...
... SHENZHEN, China , Aug. 4 ... NPD ) ("Nepstar" or "the Company"), the largest ... of directly operated stores,today announced that the State Administration of ... the amount of RMB25.5 million ,( US$3.8 million ) ...
Cached Medicine Technology:American Oriental Bioengineering to Report Second Quarter 2010 Financial Results on August 9, 2010 2China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 2China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 3China Nepstar Chain Drugstore Reports One-time Non-recurring Penalty Payment 4
(Date:8/30/2014)... Colorado Springs, CO (PRWEB) August 30, 2014 ... valuable, and increasingly difficult to get. Snoring and sleep apnea ... breathing stops) rob people and their bed partners of the ... Up to 45% of the population snores and 20 million ... these, only 10% have been diagnosed and treated; and of ...
(Date:8/30/2014)... AZ (PRWEB) August 30, 2014 Hastings ... personal injury attorneys located throughout Arizona is pleased to ... This is one specific example among many cases where ... clients are able to retain a greater portion of ... after case that providing a positive solution for Arizona ...
(Date:8/30/2014)... 2014 "My wife suffered neck, back ... accident," said one of two inventors from Bethel, Alaska. ... shoulder and neck area. She tried other pillows to ... pressure, assisting in comfort and providing extra sleep." , ... to support the head, neck and back comfortably. This ...
(Date:8/30/2014)... colchicine, a plant-based medication commonly used to treat ... results in reducing potential complications from this type ... of gastrointestinal adverse effects, according to a study ... being released early online to coincide with its ... , Common complications after cardiac surgery include postpericardiotomy ...
(Date:8/30/2014)... Market Research Report on Global ... professional and in-depth market survey on Global and ... the basic information of Lab Oven including its ... explores global and China’s top manufacturers of Lab ... and market share etc. , The report further ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... It is a Herculean task to lose the excess weight that ... flooding the market but the best way is that adopted earlier ... down on the extra calories. Obesity is a big problem these ... be the mainstay of approach towards weight control., ,With so ...
... as soon as it is spoken out loud’. ~Hermann ... task, more so, in the case of sudden mysterious // ... in such situations, the pursuit of forensic medicine has been ... the science that deals with determining causes, manner and circumstances ...
... Harvard Mental Health Letter had published a report on a ... ,According to the Harvard Mental Health Letter, tests of ... predict whether healthy elderly people will develop Alzheimer’s. In one ... certain level on a test of delayed word recall developed ...
... affect younger men with clogged arteries leading to a condition ... current issue of Psychosomatic Medicine. However, women in the same ... the study., ,The researchers from University of Helsinki in ... carotid arteries, which supply blood to the head, in men ...
... has shown that use of magnetic insoles in shoes do ... of Mayo Clinic Proceedings, the researchers from Mayo Clinic ... in relieving pains., ,Searchers for the study had said ... magnets based on personal recommendations or belief systems, often without ...
... A new scorecard to enable easy identification of diabetics ... in India, Britain and Australia. This venture has been ... Federation, and the WHO centre for diabetes and the ... developed the Indian Diabetes Risk Score in collaboration with ...
Cached Medicine News:Health News:Forensic Phonetics – Scientific Solution for Legal Problem 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: